| pubmed-article:17398197 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17398197 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:17398197 | lifeskim:mentions | umls-concept:C0021270 | lld:lifeskim |
| pubmed-article:17398197 | lifeskim:mentions | umls-concept:C0344925 | lld:lifeskim |
| pubmed-article:17398197 | lifeskim:mentions | umls-concept:C1521802 | lld:lifeskim |
| pubmed-article:17398197 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:17398197 | pubmed:dateCreated | 2007-4-2 | lld:pubmed |
| pubmed-article:17398197 | pubmed:abstractText | There are very few published reports of the transcatheter closure of perimembranous ventricular septal defects (PMVSDs) using the Amplatzer PMVSD occluder with encouraging initial results. This report presents initial and 1-year results from 54 patients with PMVSDs who underwent transcatheter closure at 5 different institutions with the Amplatzer PMVSD occluder. Sixty-five patients with PMVSDs were enrolled at 5 European centers. Eleven of the 65 patients did not fulfill the patient selection criteria at the initial echocardiographic evaluation or at cardiac catheterization. As a result, a total of 54 patients underwent attempted transcatheter closure using the Amplatzer PMVSD occluder. The median age of the patients was 5.1+/-3.6 years (range 0.3 to 13), and the median weight 18.5+/-10.3 kg (range 5 to 45). Devices were permanently implanted in 49 of 54 patients. Complete occlusion of the communication at 1-year follow-up was observed in 46 of 49 patients (94%). Main early procedural complications included (1) device embolization (2 patients), (2) severe bradycardia with hemodynamic compromise (2 patients), and (3) Mobitz II (2:1) heart block (1 patient). Late procedural complications included complete heart block (1 patient). No other complications were observed during follow-up. In conclusion, the Amplatzer PMVSD occluder is promising device that can be used for transcatheter closure in selected patients with PMVSDs. Further studies and long-term follow-up are required before this technique enters routine clinical practice. | lld:pubmed |
| pubmed-article:17398197 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17398197 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17398197 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17398197 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:17398197 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17398197 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:17398197 | pubmed:issn | 0002-9149 | lld:pubmed |
| pubmed-article:17398197 | pubmed:author | pubmed-author:StefanadisChr... | lld:pubmed |
| pubmed-article:17398197 | pubmed:author | pubmed-author:OttenkampJaap... | lld:pubmed |
| pubmed-article:17398197 | pubmed:author | pubmed-author:ThanopoulosBa... | lld:pubmed |
| pubmed-article:17398197 | pubmed:author | pubmed-author:BlomNicoN | lld:pubmed |
| pubmed-article:17398197 | pubmed:author | pubmed-author:RigbyMichael... | lld:pubmed |
| pubmed-article:17398197 | pubmed:author | pubmed-author:KaranasiosEva... | lld:pubmed |
| pubmed-article:17398197 | pubmed:author | pubmed-author:ZarayelyanArm... | lld:pubmed |
| pubmed-article:17398197 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17398197 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:17398197 | pubmed:volume | 99 | lld:pubmed |
| pubmed-article:17398197 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17398197 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17398197 | pubmed:pagination | 984-9 | lld:pubmed |
| pubmed-article:17398197 | pubmed:dateRevised | 2007-11-2 | lld:pubmed |
| pubmed-article:17398197 | pubmed:meshHeading | pubmed-meshheading:17398197... | lld:pubmed |
| pubmed-article:17398197 | pubmed:meshHeading | pubmed-meshheading:17398197... | lld:pubmed |
| pubmed-article:17398197 | pubmed:meshHeading | pubmed-meshheading:17398197... | lld:pubmed |
| pubmed-article:17398197 | pubmed:meshHeading | pubmed-meshheading:17398197... | lld:pubmed |
| pubmed-article:17398197 | pubmed:meshHeading | pubmed-meshheading:17398197... | lld:pubmed |
| pubmed-article:17398197 | pubmed:meshHeading | pubmed-meshheading:17398197... | lld:pubmed |
| pubmed-article:17398197 | pubmed:meshHeading | pubmed-meshheading:17398197... | lld:pubmed |
| pubmed-article:17398197 | pubmed:meshHeading | pubmed-meshheading:17398197... | lld:pubmed |
| pubmed-article:17398197 | pubmed:meshHeading | pubmed-meshheading:17398197... | lld:pubmed |
| pubmed-article:17398197 | pubmed:meshHeading | pubmed-meshheading:17398197... | lld:pubmed |
| pubmed-article:17398197 | pubmed:meshHeading | pubmed-meshheading:17398197... | lld:pubmed |
| pubmed-article:17398197 | pubmed:meshHeading | pubmed-meshheading:17398197... | lld:pubmed |
| pubmed-article:17398197 | pubmed:meshHeading | pubmed-meshheading:17398197... | lld:pubmed |
| pubmed-article:17398197 | pubmed:meshHeading | pubmed-meshheading:17398197... | lld:pubmed |
| pubmed-article:17398197 | pubmed:meshHeading | pubmed-meshheading:17398197... | lld:pubmed |
| pubmed-article:17398197 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17398197 | pubmed:articleTitle | Transcatheter closure of perimembranous ventricular septal defects in infants and children using the Amplatzer perimembranous ventricular septal defect occluder. | lld:pubmed |
| pubmed-article:17398197 | pubmed:affiliation | Department of Cardiology, Aghia Sophia Children's Hospital, and University of Athens, Greece. vasiliosthanopoulos@usa.net | lld:pubmed |
| pubmed-article:17398197 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17398197 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17398197 | lld:pubmed |
